Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

NCT05006469 is registered in ClinicalTrials.gov with Liao Aijun as lead sponsor.

NCT NCT05006469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05006469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma
Lead sponsor
Liao Aijun
Phase
Phase 3
Overall status
Unknown status
Start date
June 1, 2021
Completion date
May 31, 2024
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bendamustine, multiple myeloma